This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Singapore, Tunisia, United Kingdom, United States, South Africa
The drug ATROVENT contains one active pharmaceutical ingredient (API):
1
Ipratropium bromide anhydrous
UNII J697UZ2A9J - IPRATROPIUM BROMIDE
|
Ipratropium is a quaternary ammonium compound with anticholinergic (parasympatholytic) properties. Ipratropium appears to inhibit vagally mediated reflexes by antagonising the action of acetylcholine, the transmitter agent released from the vagus nerve. Anticholinergics prevent the increase in intracellular concentration of Ca++, which is caused by interaction of acetylcholine with the muscarinic receptor on bronchial smooth muscle. Ca++ release is mediated by the second messenger system consisting of IP3 (inositol triphosphate) and DAG (diacylglycerol). |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
ATROVENT HFA Inhalation aerosol, metered | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
ATROVENT Nebuliser solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
R01AX03 | Ipratropium bromide | R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AX Other nasal preparations |
R03BB01 | Ipratropium bromide | R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BB Anticholinergics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 1542E, 4089F, 4090G, 8238N, 8671J |
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 504500501178319, 504500504177313 |
Country: CA | Health Products and Food Branch | Identifier(s): 02247686 |
Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 25.076-04-03, 29385-1-09-10 |
Country: EE | Ravimiamet | Identifier(s): 1057711, 1105940, 1567470, 1874448 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 54674, 61184, 61185, 61848 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 099486, 129817 |
Country: FR | Base de données publique des médicaments | Identifier(s): 61267669, 65756091, 66698997, 66871253, 67838060, 69720897 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 180714, 201649, 299787, 299788, 299790, 299791, 32225, 32266, 375964, 73900 |
Country: HK | Department of Health Drug Office | Identifier(s): 23564, 36372, 50402 |
Country: HR | Agencija za lijekove i medicinske proizvode | Identifier(s): HR-H-119167758, HR-H-535873913 |
Country: IE | Health Products Regulatory Authority | Identifier(s): 14397, 67618, 71220 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 4715 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 2259702G2021 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1004213, 1084153 |
Country: MT | Medicines Authority | Identifier(s): MA211/01001, MA211/01002, PI1438/09101A, PI908/18601A |
Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 161M82, 189M97 |
Country: NL | Z-Index G-Standaard | Identifier(s): 13804510, 13804529, 14691159 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 29378, 38717, 73377 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 10628 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100008205, 100114137 |
Country: SG | Health Sciences Authority | Identifier(s): 02815P, 12002P |
Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 5213074 |
Country: US | FDA, National Drug Code | Identifier(s): 0597-0087, 50090-0961 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): 37/10.2.1/0273, Z/10.2.1/48 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.